Front Month Nymex Crude Fell 3.97% This Week to Settle at $68.18 — Data Talk
Front Month Nymex Crude for Nov. delivery lost $2.82 per barrel, or 3.97% to $68.18 this week
--Largest one week net and percentage decline since the week ending Sept. 6, 2024
--Snaps a two week winning streak
--Down nine of the past 12 weeks
--Today it is up 51.00 cents or 0.75%
--Snaps a two session losing streak
--Today's settlement value is the fifth lowest this year
--Off 24.90% from its 52-week high of $90.79 hit Friday, Sept. 29, 2023
--Up 3.70% from its 52-week low of $65.75 hit Tuesday, Sept. 10, 2024
--Down 24.90% from 52 weeks ago
--Off 21.55% from its 2024 settlement high of $86.91 hit Friday, April 5, 2024
--Up 3.70% from its 2024 settlement low of $65.75 hit Tuesday, Sept. 10, 2024
--Off 53.07% from its record high of $145.29 hit Thursday, July 3, 2008
--Month-to-date it is down 7.30%
--Year-to-date it is down $3.47 or 4.84%
All prices are calculated based on the settlement price of the current front month contract.
Source: Dow Jones Market Data
(END) Dow Jones Newswires
September 27, 2024 15:00 ET (19:00 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks